Simplify Asset Management’s Benitec Biopharma BNTC Stock Holding History
Bought
Maintained
Sold
Other funds holding BNTC
Simplify Asset Management's BNTC Position: Q2 2026 in Review
Simplify Asset Management increased its Benitec Biopharma (BNTC) stake by 79% in Q2 2026, buying an estimated $5.26M and bringing the position to 1,005,557 shares worth $13.5M. The position accounts for 0.19% of the portfolio, ranked #26.
Simplify Asset Management first reported a position in BNTC in Q2 2024 and has held it in 9 quarters since. 4 funds tracked by Wall St. Rank hold BNTC as of Q2 2026.
- Simplify Asset Management held 1,005,557 shares of Benitec Biopharma worth $13.5M as of Q2 2026.
- Simplify Asset Management bought 443,315 Benitec Biopharma shares in Q2 2026, an estimated $5.26M.
- Benitec Biopharma made up 0.19% of Simplify Asset Management's portfolio in Q2 2026, its #26 holding.
- Simplify Asset Management first reported a position in Benitec Biopharma in Q2 2024 and has held it in 9 quarters since.
- 4 funds tracked by Wall St. Rank held Benitec Biopharma as of Q2 2026.
Based on Simplify Asset Management's 13F filing for Q2 2026, filed 16 Jul 2026.